Paraffin

matrix metallopeptidase 2 ; Homo sapiens







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33778077 Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma. 2021 1
2 32314796 Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma. 2020 Aug 1
3 25259564 Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. 2014 Dec 1
4 22553708 Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. 2011 1
5 22820140 Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma. 2011-2012 1
6 18587209 Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vitro. 2008 Jun 1
7 18925697 Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer. 2008 Oct 1
8 16309203 Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. 2005 Nov-Dec 1
9 14569466 Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. 2004 Jan 1
10 15051038 Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. 2004 Apr 1
11 15571322 Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth. 2004 Jun 1
12 12602907 Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma. 2003 Jan 1
13 14624933 Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. 2003 Nov 1
14 12404291 Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. 2002 Nov 1 1
15 11245340 Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. 2001 Jan 1
16 11482578 Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. 2001 1
17 10718490 MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma. 1999 Dec 1
18 9875140 Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. 1998 Sep 1